Stay updated with breaking news from Advicenne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advicenne signs its first Sibnayal distribution agreement outside Europe with Taïba Healthcare, one of the rare disease leading pharmaceutical company in Middle East - Advicenne will receive a transfer
Changes in governance with the appointment of a new Chairman of the Board of Directors and a new Director Regrouping of all French Advicenne's teams in the new Paris headquarters to optimize
Regulatory News: Advicenne (Euronext Growth Paris ALDVI FR0013296746) (Paris:ALDVI), announces that its Combined General Meeting held on June 9, 2022, authorized the Board of Directors for a period
Regulatory News: Advicenne (Euronext Growth Paris ALDVI -FR0013296746) (Paris:ALDVI), a pharmaceutical company specializing in the development and commercialization of innovative treatments for those
Regulatory News: Advicenne (Euronext: ALDVI) (Paris:ALDVI), a pharmaceutical company specializing in the development and commercialization of innovative treatments for those suffering from rare renal